Enoximone is a selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure. Trials were halted in the U.S., but the drug is used in various countries.
For the treatment of congestive heart failure.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.